Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2014, Article ID 202943, 4 pages
http://dx.doi.org/10.1155/2014/202943
Case Report

Thymic Carcinoma Presenting as Disseminated Intravascular Coagulation

University of Alabama Birmingham Montgomery Internal Medicine, Montgomery, AL 36116, USA

Received 20 March 2014; Revised 4 September 2014; Accepted 4 September 2014; Published 12 November 2014

Academic Editor: Annekathryn Goodman

Copyright © 2014 Mamatha Siricilla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. A. Engels and R. M. Pfeiffer, “Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies,” International Journal of Cancer, vol. 105, no. 4, pp. 546–551, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. “Proceedings of the First International Conference on Thymic Malignancies. August 20-21, 2009. Bethesda, Maryland, USA,” Journal of Thoracic Oncology, vol. 5, no. 10, supplement 4, pp. S259–S370.
  3. A. Marx, R. Rieker, A. Toker, F. Länger, and P. Ströbel, “Thymic carcinoma: is it a separate entity? From molecular to clinical evidence,” Thoracic Surgery Clinics, vol. 21, no. 1, pp. 25–31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. A. Moran, A. Weissferdt, N. Kalhor et al., “Thymomas I: a clinicopathologic correlation of 250 cases with emphasis on the World Health Organization schema,” The American Journal of Clinical Pathology, vol. 137, no. 3, pp. 444–450, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Levi and H. Ten Cate, “Disseminated intravascular coagulation,” The New England Journal of Medicine, vol. 341, no. 8, pp. 586–592, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. H. ten Cate, J. J. Timmerman, and M. Levi, “The pathophysiology of disseminated intravascular coagulation,” Thrombosis and Haemostasis, vol. 82, no. 2, pp. 713–717, 1999. View at Google Scholar · View at Scopus
  7. A. Ouyang, L. Y. Zhou, L. Q. Zeng, F. L. Li, and G. R. Dou, “Thymus carcinoma associated with Cushing's syndrome and disseminated intravascular coagulation. A case report,” Chinese Medical Journal, vol. 96, no. 3, pp. 229–232, 1983. View at Google Scholar
  8. M. J. Sworn, F. E. Preston, and F. McGinty, “Disseminated intravascular coagulation with thymoma-associated Cushing's syndrome,” The British Medical Journal, vol. 2, no. 5862, pp. 343–344, 1973. View at Publisher · View at Google Scholar · View at Scopus
  9. H. B. Dib, B. Friedman, H. I. Khoull, D. R. Gerber, and R. L. Weiss, “Malignant thymoma: a complicated triad of SVC syndrome, cardiac tamponade, and DIC,” Chest, vol. 105, no. 3, pp. 941–942, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. F. C. Detterbeck, A. G. Nicholson, K. Kondo, P. van Schil, and C. Moran, “The masaoka-koga stage classification for thymic malignancies: clarification and definition of terms,” Journal of Thoracic Oncology, vol. 6, supplement 3, no. 7, pp. S1710–S1716, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. E. Lewis, M. R. Wick, B. W. Scheithauer, P. E. Bernatz, and W. F. Taylor, “Thymoma: a clinicopathologic review,” Cancer, vol. 60, no. 11, pp. 2727–2743, 1987. View at Google Scholar · View at Scopus
  12. A. Masaoka, “Staging system of thymoma,” Journal of Thoracic Oncology, vol. 5, no. 10, supplement 4, pp. S304–S312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Kondo and Y. Monden, “Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan,” Annals of Thoracic Surgery, vol. 76, no. 3, pp. 878–884, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Y. Eng, C. D. Fuller, J. Jagirdar, Y. Bains, and C. R. Thomas Jr., “Thymic carcinoma: state of the art review,” International Journal of Radiation Oncology, Biology, Physics, vol. 59, no. 3, pp. 654–664, 2004. View at Google Scholar
  15. K. Kondo, K. Yoshizawa, M. Tsuyuguchi et al., “WHO histologic classification is a prognostic indicator in thymoma,” Annals of Thoracic Surgery, vol. 77, no. 4, pp. 1183–1188, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Lauriola, R. A. Erlandson, and J. Rosai, “Neuroendocrine differentiation is a common feature of thymic carcinoma,” The American Journal of Surgical Pathology, vol. 22, no. 9, pp. 1059–1066, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Giaccone, “Treatment of thymoma and thymic carcinoma,” Annals of Oncology, vol. 11, supplement 3, pp. 245–246, 2000. View at Google Scholar · View at Scopus
  18. C. B. Falkson, A. Bezjak, G. Darling et al., “The management of thymoma: a systematic review and practice guideline,” The Journal of Thoracic Oncology, vol. 4, no. 7, pp. 911–919, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. K. De Keyzer, P. Peeters, C. Verhelst, A. Dendooven, A. Vonck, and R. Vanholder, “Autoimmune haemolytic anaemia associated with a thymoma: case report and review of the literature,” Acta Clinica Belgica, vol. 64, no. 5, pp. 447–451, 2009. View at Google Scholar · View at Scopus
  20. M. Djaldetti, A. Blay, M. Bergman, H. Salman, and H. Bessler, “Pure red cell aplasia—a rare disease with multiple causes,” Biomedicine and Pharmacotherapy, vol. 57, no. 8, pp. 326–332, 2003. View at Publisher · View at Google Scholar · View at Scopus